The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The virus binds to the target host cell via the ...

Please provide your email address to receive an email when new articles are posted on . RAS blockers had similar mortality benefit by race in patients with HFrEF. RAS blockers improved HF ...

Patients infected by the COVID-19 virus may benefit from treatments that dampen the renin–angiotensin system, according to a review of several animal studies. These preclinical findings generally ...

The renin-angiotensin system (RAS) remains a cornerstone of cardiovascular and renal physiology, orchestrating vital aspects of blood pressure regulation and fluid-electrolyte balance. At the heart of ...

The renin-angiotensin system (RAS) becomes active at low blood pressure and forms angiotensin II, a hormone that causes blood vessels to constrict, causing blood pressure to rise again. The enzyme ...

Angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor antagonists have become an important tool for the treatment of hypertension and its cardiovascular complications. Inhibition ...

If renin-angiotensin system inhibitors are indicated in patients with advanced CKD, they should not be stopped just because of low eGFR, investigators concluded. Discontinuing renin-angiotensin system ...

Please provide your email address to receive an email when new articles are posted on . Discontinuation of RAS therapy before major noncardiac surgery did not impact postoperative outcomes vs.

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included ...

pills Findings may aid physicians in their clinical decision-making in the absence of randomized clinical trial data, according to investigators. Halting renin-angiotensin system (RAS) inhibitors in ...

Circulating tumor cells (CTC) in mesothelioma and its cytomorphological and immunohistochemical correlation with the primary tumor specimens. Fluorodeoxiglucose (FDG)-avidity at positron emission ...